| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |